Genpact (G) Earnings: Q3 2026 Results and Next Report Date

The quarter ended September 30, 2026 and Genpact published the results on November 5, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Genpact reports EPS two ways: GAAP, under the accounting rules every US filer follows, and adjusted, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Effective January 1, 2026, Genpact splits revenue between Advanced Technology Solutions and Core Business Services, replacing its earlier Data-Tech-AI and Digital Operations split. Its reportable segments remain Financial Services, Consumer and Healthcare, and High Tech and Manufacturing.
• Genpact is asking shareholders to let its board move the company's incorporation from Bermuda to Delaware. If approved and effected, the change is expected on or around March 1, 2027.

Source: Genpact Q3 2026 results, November 5, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How Genpact splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• Genpact's Advanced Technology Solutions revenue was $405 million in Q3 2026, up 30% from $311 million in Q3 2025, 29% of total revenue.
• Genpact's Core Business Services revenue was $980 million in Q3 2026, flat on $980 million in Q3 2025, 71% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 2026 release, Genpact said:

“Net revenue growth of at least 7% year-over-year on an as reported basis, or 6.8% on a constant currency basis.”

“In Advanced Technology Solutions, we expect revenue to grow at least 25% year-over-year.”

“In Core Business Services, we expect growth to continue year-over-year.”

“Gross margin outlook increased to approximately 36.9%, up approximately 90 basis points year-over-year.”

Source: Genpact Q3 2026 release, Nov 5, 2026.

This is the company's own guidance as of Nov 5, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the G forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP net revenues and diluted EPS, each as first reported in that quarter's release.

Genpact's next report is expected around February 4, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q3 2026 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 5, 2026

Genpact reported net revenues of $1,385.4 million in Q3 2026, up 7.3% from $1,291.3 million a year earlier and 7.5% on a constant currency basis. Advanced Technology Solutions brought in $405.1 million, up 30.3%, or 29% of the total. Core Business Services brought in $980.3 million, the same as a year earlier, or 71% of the total. (Genpact Q3 2026 release, Nov 5, 2026; Genpact Form 10-Q, Q3 2026, Nov 6, 2026)

Genpact said the Advanced Technology Solutions increase was broad-based, driven by demand for digital technology, data and AI, and advisory solutions and services, as well as agentic solutions. In Core Business Services, higher technology services revenue was largely offset by Genpact's transition away from certain engagements not aligned with its Agentic Operations strategy. The currency effect in the quarter came mainly from the Australian dollar against the U.S. dollar. (Genpact Form 10-Q, Q3 2026, Nov 6, 2026)

By reportable segment, High Tech and Manufacturing was the largest at $541.6 million, up 4.4%, followed by Consumer and Healthcare at $475.7 million, up 10.7%, and Financial Services at $368.1 million, up 7.4%. Genpact tied the Financial Services gain to data and AI and advisory demand plus ramp-ups of existing and recently signed deals, and said the transition away from non-aligned engagements partly offset growth in High Tech and Manufacturing. (Genpact Form 10-Q, Q3 2026, Nov 6, 2026)

Genpact's revenue is concentrated by geography and by client. In 2025, 71% of its revenues came from clients based in North America and 22% from clients based in Europe. Its top five clients made up 15.2% of 2025 net revenues and its top ten clients 23.4%. Average headcount fell 3.5% to about 141,700 in Q3 2026 from about 146,800 a year earlier. (Genpact Form 10-K, 2025, Feb 26, 2026; Genpact Form 10-Q, Q3 2026, Nov 6, 2026)

Genpact's GAAP diluted EPS was $0.89 in Q3 2026, against $0.83 a year earlier, and its adjusted diluted EPS was $1.07, against $0.97. The adjusted figure adds back stock-based compensation ($0.18 per share), amortization of acquired intangible assets ($0.02) and acquisition-related expenses, less the tax impact of those items. Stock-based compensation expense rose to $31.2 million from $22.2 million. (Genpact Q3 2026 release, Nov 5, 2026)

Income from operations rose 10.1% to $211.0 million, but net income rose 4.0% to $151.7 million. Net interest expense increased to $16.5 million from $12.8 million because of a higher rate on Senior Notes issued in November 2025, and other income fell to $1.0 million from $6.8 million on deferred compensation plan assets. SG&A rose 19.2% to $312.5 million, which Genpact attributed to investment in agentic engineering and sales and marketing, a higher allowance for credit losses and higher stock-based compensation. The effective tax rate was 22.8%, down from 23.0%. (Genpact Form 10-Q, Q3 2026, Nov 6, 2026)

Diluted weighted average shares were 169,627,481 in the quarter, against 176,104,577 a year earlier. Genpact repurchased approximately 870,000 shares for about $31 million at an average price of $35.49 and paid about $31 million in dividends. Year to date it returned approximately $246 million through repurchases and dividends. (Genpact Q3 2026 release, Nov 5, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Genpact publishes a full-year outlook in its release and updates it each quarter. With Q3 2026 it raised its 2026 gross margin outlook to approximately 36.9% and its adjusted diluted EPS growth outlook to at least 13%. It kept net revenue growth of at least 7% as reported (6.8% in constant currency), Advanced Technology Solutions growth of at least 25%, and an adjusted income from operations margin of approximately 17.7%. (Genpact Q3 2026 release, Nov 5, 2026)

Genpact's reconciliation of that outlook puts 2026 GAAP diluted EPS at $3.55 and adjusted diluted EPS at $4.14, with a GAAP income from operations margin of 15.2%. (Genpact Q3 2026 release, Nov 5, 2026)

A consensus figure is the average of the models published by the analysts who cover Genpact, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Genpact's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning G is on is G a buy or a sell?, what analysts expect next is on the G forecast, and what the company does is on the Genpact (G) stock page.

Every number on this page can be traced to a document Genpact published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.